Benitec Biopharma Ltd ADR (BNTC NASDAQ) stock market data APIs
$13.2455
-0.13(-1%)
as of November 14, 2025
Try our APIs with
free plan!
Benitec Biopharma Ltd ADR Financial Data Overview
Price chart is built with
Anychart
Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. Its Silence and Replace, a DNA-directedRNA interference platform combines RNA interference with gene therapy to create medicines that simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct. The company is developing BB-301, an AAV-based gene therapy designed to silence the expression of the disease-causing gene for the treatment of oculopharyngeal muscular dystrophy related dysphagia. Benitec Biopharma Inc. is headquartered in Hayward, California.
Prev. Close
13.2455
Open
13.1117
High
13.3551
Low
12.5521
52 wk Range
9.1-17.15
Market Cap
443 M
Shares Outstanding
33 662 K
Revenue
7 000
EPS
-0.42
Beta
0.176
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Benitec Biopharma Ltd ADR (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Benitec Biopharma Ltd ADR data using free add-ons & libraries
Get Benitec Biopharma Ltd ADR Fundamental Data
Benitec Biopharma Ltd ADR Fundamental data includes:
- Net Revenue: 7 000
- EBITDA: -41 699 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-09-23
- EPS/Forecast: -0.3129
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Benitec Biopharma Ltd ADR News
New
Benitec GAAP EPS of -$0.22
* Benitec press release [https://seekingalpha.com/pr/20308734-benitec-biopharma-releases-first-quarter-2026-financial-results-and-provides-operational] (BNTC [https://seekingalpha.com/symbol/BNTC]):...
Benitec Biopharma Releases First Quarter 2026 Financial Results and Provides Operational Update
–Fast Track Designation was granted for BB-301 following U.S. Food and Drug Administration (FDA) review of positive interim clinical study results and proprietary Responder Analysis planned for use ...
Big Insider Purchases by Carl Icahn, Mario Gabelli, and Others
santiphotois / Getty Images In the past week or so, beneficial owners Carl Icahn and Mario Gabelli made some big bets in Monro Inc. (NASDAQ: MNRO) and Gabelli Healthcare & WellnessRx Trust (NYSE: GRX...
Benitec Biopharma prices $100M stock offering
* Benitec Biopharma (BNTC [https://seekingalpha.com/symbol/BNTC]) priced [https://seekingalpha.com/pr/20295927-benitec-biopharma-inc-announces-pricing-of-100-million-common-stock-offering] its under...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
